A catalyst project, paving the way for future development on the wider campus.
Client
CPI
Highlights
- Innovative research and development facility supporting the UK’s pharmaceutical and fine chemicals industry in accelerating manufacturing processes
- Fluid and dynamic design allowing for reconfiguration and expansion
An innovative research, development and manufacturing facility, the new Medicines Manufacturing Innovation Centre (MMIC) in Renfrewshire supports the UK’s pharmaceutical and fine chemicals industries in accelerating a new generation of manufacturing processes.
A joint project between CPI, the University of Strathclyde, UK Research and Innovation, Scottish Enterprise, GSK and AstraZeneca, the Centre provides academics, research scientists and manufacturing partners with access to cutting-edge technical equipment and knowledge. It aims to encourage collaboration to develop new technologies and processes that will increase productivity in medicines manufacturing.
BakerHicks supported CPI and their partners facilitating industry-wide stakeholder workshops and evaluated design options to develop the project brief.
They were appointed to deliver multi-disciplinary design services, including architecture, civil and structural, mechanical and electrical, pharmaceutical consultancy, and process engineering, to RIBA Stage 3. The team worked closely with the main contractor as a principal designer advisor through the construction phases.
Services
-
RIBA 3 multi-disciplinary design
-
Principal Designer Advisor
Project facts
-
88 m(£)
state-of-the-art facility